Hutchmed (China) Ltd (HCM)

On September 3, HUTCHMED (China) Limited (NASDAQ:HCM) announced an exclusive global development and licensing agreement with GSK plc (NYSE:GSK) for HMPL-A830, targeting colorectal, pancreatic, and lung...

HUTCHMED stock soared on Thursday after the company announced a new licensing deal with GlaxoSmithKline.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. HUTCHMED (China) Limited (NASDAQ:HCM) is one of the most undervalued pharma stocks.

In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In.

We came across a bullish thesis on Paycom Software, Inc. on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PAYC.

In this piece, we will take a look at the 10 cheap pharmaceutical stocks to buy according to short sellers. The pharmaceutical industry is one of the most interesting sectors to invest in.

In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.